Campport - The Future of Biotech?

Campport has two programs that we are intending to submit I and D's for this year. One is a disease called your VA syndrome, which is a rare genetic epilepsy affecting children and adults. We also have another very exciting drug for a rare genetic disease called your RIA cycle disorders. If we submit an I and D later this year, that will be within three years, we've gone from screen to I and D,. And that's the power of our platform and being able to use a programmable therapeutic.